Skip to main content
. 2024 May 10;9(4):896–906. doi: 10.1177/23969873241249295

Table 1.

Baseline characteristics of patients before PSM.

Variable a No anticoagulation, N = 430 (66%) Anticoagulation, N = 223 (34%) p-value b
Male, n (%) 202 (47) 117 (52) 0.18
Age, median (IQR) 74 (64, 82) 78 (69, 84) <0.001
Hypercholesterolemia, n (%) 145 (37) 110 (50) <0.001
Hypertension, n (%) 276 (64) 167 (75) 0.006
Diabetes, n (%) 118 (28) 51 (23) 0.2
Atrial fibrillation, n (%) 111 (26) 172 (77) <0.001
Current smokers, n (%) 58 (14) 26 (12) 0.5
Previous use of antiplatelet drugs, n (%) 156 (36) 45 (21) <0.001
Baseline mRS (0–1), n (%) 328 (78) 154 (70) 0.022
Baseline mRS (0–2), n (%) 365 (87) 189 (86) 0.68
Site of initial occlusion 0.47
 Medium (M2) 366 (85) 185 (83)
 Distal (M3, M4) 64 (15) 38 (17)
ASPECTS, Median (IQR) 9.00 (7.00, 10.00) 9.00 (8.00, 10.00) 0.15
Baseline NIHSS, Median (IQR) 9 (5, 16) 12 (7, 18) 0.002
First line technique, n (%) 0.024
 Aspiration 105 (25) 35 (16)
 Both 252 (60) 152 (69)
 Stentretriever 65 (15) 32 (15)
Mothership versus drip and ship, n (%) 0.78
 Drip and ship 172 (41) 93 (42)
 Mothership 250 (59) 129 (58)
Onset to arterial puncture (min), Median (IQR) 356 (210, 661) 263 (186, 411) <0.001
Onset to recanalization (min), Median (IQR) 403 (260, 696) 324 (230, 473) <0.001
Anesthesia, n (%) 0.84
CS/LA 285 (68) 151 (69)
GA 133 (32) 68 (31)
Puncture site, n (%) 0.26
 Femoral 294 (97) 138 (95)
 Radial 8 (2.6) 7 (4.8)
Imaging after MT, n (%) 0.14
 CT 265 (64) 146 (69)
 Both 70 (17) 22 (10)
 MRI 76 (18) 44 (21)
 No imaging 3 (0.7) 1 (0.5)
a

mRS: modified Rankin scale; NIHSS: National Institutes of Health Stroke Scale; ASPECTS: Alberta Stroke Program Early CT Score; CS/LA: conscious sedation/local anesthesia; GA: general anesthesia.

b

Pearson’s chi-squared test; Wilcoxon rank sum test; Fisher’s exact test.